Skip to main
AVDL

Avadel Pharma (AVDL) Market Capitalization Overview

Market Cap: $2.11B as of Jan 8, 2026

$2.11B
$15.66M (0.75%)past month
As of Jan 8, 2026, Avadel Pharma (AVDL) has a market capitalization of $2.11B. Over the past 30 days, its market cap has increased by 0.47%, while in the last 12 months, it has decreased by -0.32%.

Market capitalization represents the total value of Avadel Pharma as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Avadel Pharma (AVDL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Avadel Pharma (AVDL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Avadel Pharma (AVDL) Market Cap History

DateMarket CapChange
Dec 1, 2025$2.10B+13.86%
Nov 3, 2025$1.85B+26.34%
Oct 1, 2025$1.46B+0.13%
Sep 2, 2025$1.46B+35.48%
Aug 1, 2025$1.08B+25.77%
Jul 1, 2025$853.63M-7.02%
Jun 2, 2025$918.06M+10.35%
May 1, 2025$831.98M+14.65%
Apr 1, 2025$725.69M-0.25%
Mar 3, 2025$727.53M-5.27%
Feb 3, 2025$768.01M-27.55%
Jan 2, 2025$1.06B-5.09%

Avadel Pharma (AVDL) End of Year Market Cap History

DateMarket CapChange
2026$2.11B-0.32%
2025$2.11B+108.14%
2024$1.02B-19.77%
2023$1.27B+189.56%
2022$435.94M-7.96%
2021$473.62M

FAQs About Avadel Pharma (AVDL) Market Cap

As of Jan 8, 2026, the market capitalization of Avadel Pharma (AVDL) is $2.11B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Avadel Pharma’s market capitalization has increased by 0.7500%, changing from $2.09B to $2.11B as of Jan 8, 2026.

In the last 3 months, Avadel Pharma’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Avadel Pharma’s market capitalization increased from $1.02B in January to $2.11B in December, reflecting a 108.14% change.

In the past five years, Avadel Pharma (AVDL) has had a compound annual growth rate (CAGR) of 34.80% in market capitalization. This means its market cap has grown at an average rate of 34.80% per year.

Avadel Pharma (AVDL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.